Skip to content

Who We Are
- Who We Are
  
  We are a collaborative fund dedicated to ending six neglected tropical diseases that affect more than 1.4 billion people.
  
  The Board
  
  The Staff
  
  Partners
  
  Anchor Investors
What We Do
- What We Do
  
  We efficiently put drug donations and private capital to work in support of country-led NTD programs that are innovative, integrated, cost-effective, and sustainable.
  
  Our Approach
  
  Our Story
  
  Our Impact
  
  Impact Stories
  
  THE LEGACY OF Pharmaceutical Partnerships
  
  Learn how pharmaceutical partnerships are driving the fight against neglected tropical diseases.
  
  Learn more
Support Our Work
- Support Our Work
  
  We believe that investing should be a transformative experience that enhances the lives of partners and beneficiaries alike. Support our mission and join us.
  
  INVEST
  
  The END Fund is dedicated to fighting the six most prevalent neglected tropical diseases, which affect 1.495 billion people globally.
  
  Annual reports
  
  Explore our annual reports and learn about the END Fund’s impact.
  
  Watch
  
  How the END Fund will end neglected tropical diseases.
Our Focus
- We focus on the six most prevalent NTDs that have proven cost-effective interventions: river blindness, lymphatic filariasis, trachoma, intestinal worms, schistosomiasis, and visceral leishmaniasis.
  
  Intestinal Worms
  
  Intestinal worms (also known as soil-transmitted helminths) cause malnutrition, anemia, and poor physical and mental growth.
  
  River Blindness
  
  River blindness (also known as onchocerciasis) is an eye and skin infection caused by parasitic worms that leads to intense itching and vision loss.
  
  Schistosomiasis
  
  Schistosomiasis (also known as bilharzia or snail fever) is a chronic disease caused by parasitic worms that live in freshwater snails.
  
  Lymphatic Filariasis
  
  Lymphatic filariasis (also known as elephantiasis) is a mosquito-borne disease that causes disfigurement and longterm disability.
  
  Trachoma
  
  Trachoma is a bacterial infection of the eye that can cause irreversible blindness. It is the leading cause of blindness due to infection worldwide.
  
  Visceral Leishmaniasis
  
  Visceral leishmaniasis (also known as kala-azar) is a life-threatening disease caused by leishmania parasites, transmitted by female sandflies.

Search

Search

Search The End Fund

Search

The End Fund Team

Our Team

Search the END Fund’s team by staff name or department

Select Department

Alan McCormick

Board Vice Chair (US, UK, Kenya)

Alison Ower

Senior Analyst, Measurement, Evaluation & Learning

Anne Heggen

Senior Director, International Programs

Ariane Cartwright

Director, Investor Relations

Brandon Green

Senior Associate, Portfolio Management

Carol Karutu

Vice President, International Programs

Carole Wainaina

Board Member (Kenya)

Catherine Garces

Senior Associate Director, Investor Relations

Cecilia Lin

Senior Associate Director, Finance & Administration

Christine board picture.

Christine Wächter-Campbell

Board Member (US)

Christopher Burrowes

Director, Operations

Daniel Boakye

Senior Technical Advisor, International Programs

Diana Kendi Makale

Associate Director, Investor Relations

Dorcus Ngaruiya

Senior Associate Director, Culture & Talent

Dr. Kebron Haile

Senior Technical Advisor, International Programs

USA: 2 Park Avenue , 28th Floor , New York, NY, 10016 phone: +1 646-690-9775 

UK: 495 Green Lanes, Palmer Green London, N13 4BS

Kenya: P.O. Box 10752 – 00100, Nairobi.

[email protected]

The END Fund Inc. is a 501(c)(3), tax-exempt charitable organization registered in the United States (EIN 27-3941186). The END Fund is a company limited by guarantee registered in England and Wales (company number 6350698) and a UK registered charity (number 1122574). The END Fund Kenya is a a non-governmental organization registered in the Republic of Kenya as NGO-POFQMD.

–

–

State Non-Profit Disclosures

–

US Gift Acceptance Policy

–

UK Gift Acceptance Policy

–

Annual Reports and Financial Statements

–

LinkedIn
Instagram
YouTube
Facebook

Subscribe to Newsletter

Crafted by Cornershop Creative

© 2024 The End Fund All Rights Reserved